MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-17266

  1. 12,206 Posts.
    lightbulb Created with Sketch. 1085
    Hi Pharma,
    Also interesting that the Bone and Marrow transplant org attended the last FDA
    meeting.
    In my opinion to persuade the FDA that a confirmatory trial will indeed take place allowing
    Ped approval when theAssay Data is presented.

    Here's hoping.

    Aloha.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.